FDA Recommends Collaboration, Parallel Development Of Patient-Reported Outcome Tools
A new draft guidance document from the US agency on the development of instruments to measure patient-reported outcomes offers a range of approaches to improve the efficiency and quality of these important tools.
You may also be interested in...
A patient's point of view is paramount as the Center for Devices and Radiological Health embarks on a plan to conduct patient-perspective studies to ascertain what device-users want and value when it comes to health care. But don't call it a "survey" – "this is real research," CDRH compliance chief Robin Newman says.
A proposed rule from the US agency would move the in vitro diagnostics from high-risk class III to class II with special controls, eliminating the requirement for a PMA.
The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.